$EFSI
EAGLE FINANCIAL SERVICES INC
CIK:0000880641|SEC Filings
Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|||||||||
| Cash Flows from Operating Activities | |||||||||||||||
| Net Income (Loss) | $ 4,981 | $ 3,740 | $ 5,270 | $ (6,974) | $ 8,721 | $ (1,704) | |||||||||
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | |||||||||||||||
| Depreciation | 419 | 389 | |||||||||||||
| Amortization of other assets | 428 | 543 | |||||||||||||
| Origination of loans held for sale | (53,579) | (42,521) | |||||||||||||
| Proceeds from sale of loans held for sale | 54,046 | 43,418 | |||||||||||||
| Net (gain) on sales of loans | (1,658) | (1,528) | |||||||||||||
| Provision for credit losses | 3,503 | 668 | 5,464 | 1,901 | |||||||||||
| (Gain) on the sale of portfolio loans | 0 | (5) | |||||||||||||
| Loss on the sale and disposal of premises and equipment | 4 | 0 | 4 | 16 | |||||||||||
| Gain on sale of other assets | 0 | 0 | 39 | 133 | |||||||||||
| Loss on the sale of securities | 0 | 0 | 0 | 12,425 | |||||||||||
| (Gain) on the sale of other assets | (3,486) | [1] | 0 | [1] | (3,486) | [2] | 0 | [2] | |||||||
| (Gain) on the sale of other assets | 0 | 0 | 39 | 133 | |||||||||||
| Amortization of subordinated debt issuance costs | 34 | 33 | |||||||||||||
| Stock-based compensation expense | 800 | 613 | |||||||||||||
| (Accretion) of premiums and discounts on debt securities and loans, net | (515) | (273) | |||||||||||||
| Bank owned life insurance income | (573) | (551) | |||||||||||||
| Changes in assets and liabilities: | |||||||||||||||
| (Increase) in other assets | (17,419) | (539) | |||||||||||||
| (Decrease) increase in other liabilities | (952) | (3,984) | |||||||||||||
| Net cash (used in) provided by operating activities | (8,227) | 8,366 | |||||||||||||
| Cash Flows from Investing Activities | |||||||||||||||
| Proceeds from maturities, calls, and principal payments of securities available for sale | 16,289 | 6,899 | |||||||||||||
| Proceeds from the sale of securities available for sale | 0 | 0 | 0 | 86,822 | |||||||||||
| Purchases of securities available for sale | (9,824) | (91,155) | |||||||||||||
| Proceeds from the sale of restricted investments | 1,931 | 3,815 | |||||||||||||
| Purchases of restricted investments | (20) | (44) | |||||||||||||
| Purchases of bank premises and equipment | (491) | (799) | |||||||||||||
| Proceeds from the sale of bank premises and equipment | 0 | 40 | |||||||||||||
| Proceeds from the sale of repossessed assets | 96 | 381 | |||||||||||||
| Proceeds from sale of other assets | 5,061 | 0 | |||||||||||||
| Proceeds from the sale of portfolio loans | 0 | 18,772 | |||||||||||||
| Net (increase) decrease in loans | (28,964) | 8,290 | |||||||||||||
| Funding of capital commitments related to other investments | 0 | (492) | |||||||||||||
| Net cash (used in) provided by investing activities | (15,922) | 32,529 | |||||||||||||
| Cash Flows from Financing Activities | |||||||||||||||
| Net increase in noninterest bearing demand deposits, savings, and interest bearing demand deposits | 23,084 | 217,456 | |||||||||||||
| Net (decrease) in time deposits | (28,509) | (26,088) | |||||||||||||
| Net increase in federal funds purchased | 11 | 172 | |||||||||||||
| Repayments of short-term Federal Home Loan Bank advances | 0 | (25,000) | |||||||||||||
| Repayments of long-term Federal Home Loan Bank advances | (40,000) | (55,000) | |||||||||||||
| Net proceeds from issuance of common stock in public offering | 0 | 53,501 | |||||||||||||
| Repurchase and retirement of common stock | (284) | (315) | |||||||||||||
| Cash dividends paid | (3,355) | (2,778) | |||||||||||||
| Net cash (used in) provided by financing activities | (49,053) | 161,948 | |||||||||||||
| (Decrease) increase in cash and cash equivalents | (73,202) | 202,843 | |||||||||||||
| Cash and Cash Equivalents | |||||||||||||||
| Beginning | $ 217,194 | $ 193,159 | 217,194 | 193,159 | $ 193,159 | ||||||||||
| Ending | $ 143,992 | $ 396,002 | 143,992 | 396,002 | $ 217,194 | ||||||||||
| Supplemental Disclosures of Cash Flow Information | |||||||||||||||
| Interest | 15,549 | 20,125 | |||||||||||||
| Income taxes | 419 | 1,200 | |||||||||||||
| Supplemental Schedule of Noncash Investing and Financing Activities: | |||||||||||||||
| Unrealized (loss) gain on securities available for sale | (1,032) | 14,358 | |||||||||||||
| Repossessed assets acquired in settlement of loans | 302 | 186 | |||||||||||||
| Lease liabilities arising from right-of-use assets | $ 204 | $ 773 | |||||||||||||
| |||||||||||||||
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Assets | ||
| Cash and due from banks | $ 18,281 | $ 13,942 |
| Interest-bearing deposits with other institutions | 71,169 | 103,984 |
| Federal funds sold | 54,542 | 99,268 |
| Total cash and cash equivalents | 143,992 | 217,194 |
| Securities available for sale, at fair value, amortized cost of $120,152 and $126,197, respectively | 112,466 | 119,543 |
| Restricted investments, at cost | 1,875 | 3,786 |
| Loans held for sale | 5,974 | 4,786 |
| Loans | 1,499,351 | 1,473,077 |
| Allowance for credit losses | (18,306) | (15,320) |
| Net Loans | 1,481,045 | 1,457,757 |
| Bank premises and equipment, net | 14,974 | 14,906 |
| Bank owned life insurance | 32,293 | 31,720 |
| Other assets | 54,746 | 38,934 |
| Total assets | 1,847,365 | 1,888,626 |
| Deposits: | ||
| Noninterest bearing demand deposits | 463,086 | 432,171 |
| Savings and interest bearing demand deposits | 720,714 | 728,545 |
| Time deposits | 418,135 | 446,644 |
| Total deposits | 1,601,935 | 1,607,360 |
| Federal funds purchased | 11 | 0 |
| Federal Home Loan Bank advances, long-term | 0 | 40,000 |
| Subordinated debt, net of unamortized issuance costs | 29,613 | 29,579 |
| Other liabilities | 21,901 | 22,848 |
| Total liabilities | 1,653,460 | 1,699,787 |
| Commitments and contingencies | ||
| Shareholders’ Equity | ||
| Preferred stock, $10 par value; 500,000 shares authorized and unissued | 0 | 0 |
| Common stock, $2.50 par value; authorized 10,000,000 shares; issued and outstanding 2026, 5,411,615 including 86,912 shares of unvested restricted stock; issued and outstanding 2025, 5,374,205 including 68,476 shares of unvested restricted stock | 13,311 | 13,264 |
| Surplus | 65,189 | 64,720 |
| Retained earnings | 121,481 | 116,115 |
| Accumulated other comprehensive loss | (6,076) | (5,260) |
| Total shareholders’ equity | 193,905 | 188,839 |
| Total liabilities and shareholders’ equity | $ 1,847,365 | $ 1,888,626 |